NeueHealth (NEUE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor. But what's the best way to find the right combination ...

Arguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. And for growth investors, double-digit earnings growth is definitely preferable, and ...

EME is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of B. Additionally, the company could be a top pick for growth investors. EME has a Growth Style Score of A, forecasting year-over-year ...

Weak commodity prices and low farm income will continue to impact farmers’ purchasing decisions and weigh on the near-term ...

Markets could see more volatility between now and the end of the year as a result. Brian Mulberry, client portfolio manager at Zacks Investment Management, said he expects investors will continue to ...

FactSet Research Systems Inc. (FDS) on Thursday reported fiscal fourth-quarter earnings of $89.5 million. On a per-share basis, the ...

LEBANON, Tenn. (AP) — LEBANON, Tenn. (AP) — Cracker Barrel Old Country Store Inc. (CBRL) on Thursday reported fiscal fourth-quarter profit of $18.1 million. The Lebanon, Tennessee-based company said ...